TETERBORO, N.J., Jan. 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Surya N. Mohapatra, Ph.D., President
and Chief Operating Officer, is scheduled to speak at the 22nd Annual JPMorgan
Healthcare Conference on Monday, January 12, 2004, at The Westin St. Francis
Hotel in San Francisco, California. The Quest Diagnostics presentation is
scheduled to begin at 11:00 a.m. Eastern Time.
The presentation will be webcast live during the conference and will be
available to registered investors on the following site:
http://equityconferences.jpmorgan.com/ and to the public on
http://www.questdiagnostics.com. In addition, the archived webcast will be
available starting approximately 24 hours after the live event until February
8, 2004.
Quest Diagnostics Incorporated is the nation's leading provider of
diagnostic testing, information and services, providing insights that enable
physicians, hospitals, managed care organizations and other healthcare
professionals to make decisions to improve health. The company offers the
broadest access to diagnostic laboratory services through its national network
of laboratories and patient service centers. Quest Diagnostics is the leading
provider of esoteric testing, including gene-based medical testing, and
empowers healthcare organizations and clinicians with state-of-the-art
connectivity solutions that improve practice management. Additional company
information can be found on the Internet at: http://www.questdiagnostics.com.
The statements in this press release, which are not historical facts or
information, may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, unanticipated expenditures, changing
relationships with customers, suppliers and strategic partners, conditions of
the economy and other factors described in the Quest Diagnostics Incorporated
2002 Form 10-K and subsequent filings.
SOURCE Quest Diagnostics Incorporated
-0- 01/09/2004
/CONTACT: Laure Park (Investors), +1-201-393-5030, or Gary Samuels
(Media), +1-201-393-5700/
/Web site: http://www.questdiagnostics.com /
(DGX)
CO: Quest Diagnostics Incorporated; JPMorgan
ST: New Jersey, California